PMID- 28360807
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 1300-0667 (Print)
IS  - 1309-4866 (Electronic)
IS  - 1300-0667 (Linking)
VI  - 53
IP  - 4
DP  - 2016 Dec
TI  - Symptomatic Remission Determines Functional Improvement and Quality of Life in 
      Schizophrenia.
PG  - 328-333
LID - 10.5152/npa.2016.11327 [doi]
AB  - INTRODUCTION: Schizophrenia is a chronic illness that negatively affects the 
      quality of life and psychosocial functions. Defined criteria to assess remission 
      in schizophrenia are considered to be useful in the long-term follow-up of 
      patients and in discriminating diagnostic factors. This study investigated the 
      quality of life and functionality in schizophrenia patients in symptomatic 
      remission (R-Sch) and not in remission (Non-R-Sch). METHODS: Sociodemographic 
      data were collected for 40 R-Sch and 40 Non-R-Sch patients, and the following 
      scales were administered: the Clinical Global Impression-Severity (CGI-S) Scale; 
      Positive and Negative Syndrome Scale (PANSS), World Health Organization Quality 
      of Life Questionnaire-Short Form, Turkish Version (WHOQOL-BREF-TR), Quality of 
      Life Scale for Schizophrenia Patients (QLS), and Global Assessment of Functioning 
      Scale (GAF). RESULTS: The total and all subscale scores of PANSS and the CGI-S 
      score were significantly lower in the R-Sch group than in the Non-R-Sch group, 
      whereas the GAF scores and all subscales of QLS and WHOQOL-BREF-TR were 
      significantly higher. CONCLUSION: This study demonstrates that improvement in 
      symptoms in schizophrenia patients improves quality and functionality in all 
      areas of life, suggesting that an improvement in symptoms is the most important 
      determinant of functional recovery in the treatment of schizophrenia.
FAU - Kokacya, Mehmet Hanifi
AU  - Kokacya MH
AD  - Department of Psychiatry, Mustafa Kemal University School of Medicine, Hatay, 
      Turkey.
FAU - Virit, Osman
AU  - Virit O
AD  - Department of Psychiatry, Gaziantep University School of Medicine, Gaziantep, 
      Turkey.
FAU - Copoglu, Umit Sertan
AU  - Copoglu US
AD  - Department of Psychiatry, Gaziantep University School of Medicine, Gaziantep, 
      Turkey.
FAU - Savas, Haluk
AU  - Savas H
AD  - Department of Psychiatry, Gaziantep University School of Medicine, Gaziantep, 
      Turkey.
FAU - Ari, Mustafa
AU  - Ari M
AD  - Department of Psychiatry, Mustafa Kemal University School of Medicine, Hatay, 
      Turkey.
FAU - Bahceci, Bulent
AU  - Bahceci B
AD  - Department of Psychiatry, Recep Tayyip Erdogan University School of Medicine, 
      Rize, Turkey.
LA  - eng
PT  - Journal Article
DEP - 20161201
PL  - Turkey
TA  - Noro Psikiyatr Ars
JT  - Noro psikiyatri arsivi
JID - 9426194
PMC - PMC5353039
OTO - NOTNLM
OT  - Schizophrenia
OT  - quality of life
OT  - symptomatic remission
COIS- Conflict of Interest: No conflict of interest was declared by the authors.
EDAT- 2017/04/01 06:00
MHDA- 2017/04/01 06:01
PMCR- 2016/12/01
CRDT- 2017/04/01 06:00
PHST- 2015/04/08 00:00 [received]
PHST- 2015/08/15 00:00 [accepted]
PHST- 2017/04/01 06:00 [entrez]
PHST- 2017/04/01 06:00 [pubmed]
PHST- 2017/04/01 06:01 [medline]
PHST- 2016/12/01 00:00 [pmc-release]
AID - npa-53-4-328 [pii]
AID - 10.5152/npa.2016.11327 [doi]
PST - ppublish
SO  - Noro Psikiyatr Ars. 2016 Dec;53(4):328-333. doi: 10.5152/npa.2016.11327. Epub 
      2016 Dec 1.